Abstrakt

Life threatening hepatotoxicity induced by Nilotinib.

Latifa Khelifa

Adverse events remain an obstacle to follow successful responding treatment. Solutions and manuscripts for monitoring drugs are essential, especially when it’s about a dangerous untoward occurrence. We report the case of 57 year-old woman with chronic myeloid leukemia who developed a rare life threatening hepatotoxicity (grade 4) secondary to Nilotinib? and how we ruled this. A monitoring of the disease as well as the treatment is mandatory.